KYNB

NASDAQStock

Kyntra Bio, Inc.

$6.98-0.04 (-0.57%)

52-Week Range

$6.84

$9.50

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.93

Volume

16.2K

Avg Volume

39.9K

Performance

-6.15%

-26.11%

YTD

-26.11%

Price Chart

ETF Exposure

KYNB is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	5	$59	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	200	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$10	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	114,179	$900K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	600	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	51	$552	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	42,428	$334K	$84.10B	0.05%

About KYNB ETF Exposure

Kyntra Bio, Inc. (KYNB) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.98. Investors can gain exposure to KYNB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KYNB, sorted by portfolio weight.